Severe mold fungal infections in critically ill patients with COVID-19
Despoina Koulenti(University of Thessaly), Stijn Blot(The University of Queensland), Marios Karvouniaris(AHEPA University Hospital), Paschalis Paranos(National and Kapodistrian University of Athens), Joseph Meletiadis(National and Kapodistrian University of Athens), Christina Routsi(National and Kapodistrian University of Athens), Νικόλαος Μάρκου(Thriasio General Hospital of Elefsina), Elisabeth Paramythiotou(Laiko General Hospital of Athens), Maria Panagiota Almyroudi(National and Kapodistrian University of Athens)
Cited by 5
Related Papers
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Infections Caused by<i>Scedosporium</i>spp
|Clinical Microbiology Reviews|2008|757
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
|Intensive Care Medicine|2012|449
Clinical and Economic Outcomes in Critically Ill Patients with Nosocomial Catheter-Related Bloodstream Infections
|Clinical Infectious Diseases|2005|425